Why CAMP4?
Leadership
About Our Name
RAP Platform
RNA Actuators
Programmable Therapeutics
Publications & Presentations
Pipeline
Investors
Newsroom
Join the Adventure
Recent News
October 11, 2024
Camp4 CEO credits CFO, investors’ ‘risk appetite’ for IPO
Read More
Contact Us
Privacy Policy
Terms of Use
Menu
31st May 2018
Camp4
31st May 2018
CAMP4 Hauls in $30M to Map New Ground with Drug Discovery Tech
31st May 2018
Startup debuts with plan to map gene signaling pathways for new targets
Top
